miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner

BACKGROUND: Gastric cancer (GC) is a common malignant disease worldwide. Aberrant miRNAs expression contributes to malignant cells behaviour, and in preclinical research, miRNA targeting has shown potential for improving GC therapy. Our present study demonstrated that miR-632 promotes GC progression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Shi, Ying, Huang, Xiaoxiao, Chen, Guobin, Wang, Ying, Liu, Yuansheng, Xu, Wei, Tang, Shaohui, Guleng, Bayasi, Liu, Jingjing, Ren, Jianlin
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322242/
https://ncbi.nlm.nih.gov/pubmed/30612555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5247-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge